HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Oncology45 papers

Anemia caused by antineoplastic agent

Last edited: 4/10/2026

Overview

Anemia is a common side effect of antineoplastic agents. Antineoplastic agents are drugs used in cancer treatment that can interfere with cell growth and division.

Diagnosis

  • No diagnostic criteria or recommended tests for anemia caused by antineoplastic agents are provided in the abstracts.
  • No grading systems for anemia caused by antineoplastic agents are provided in the abstracts.

    • Management

  • No management strategies for anemia caused by antineoplastic agents are provided in the abstracts.

    • Special Populations

  • No information on special populations (pregnancy, pediatrics, elderly, comorbidities) regarding anemia caused by antineoplastic agents is provided in the abstracts.

    • Key Recommendations

  • A quantitative microbiological assay and bioautography system with Penicillium avellaneum UC-4376 can be used for maytansine and its homologues, with a susceptibility of 1.5 mug/ml (Evidence: Weak).

    • References

    1 Hanka LJ, Barnett MS. Microbiological assays and bioautography of maytansine and its homologues. Antimicrobial agents and chemotherapy 1974. link

    Original source

    1. [1]
      Microbiological assays and bioautography of maytansine and its homologues. — Hanka LJ, Barnett MS Antimicrobial agents and chemotherapy (1974)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG